The Korea Food and Drug Administration has taken a recall action due to crystallization occurring in children's fever syrup.

Reporter Kim SangJin / approved : 2024-05-27 03:45:38
  • -
  • +
  • 인쇄
Children's fever reducer which was recalled due to crystallization. (Photo: Korea Food and Drug Administration)

 

[Alpha Biz= Reporter Kim Sangjin] According to the Korea Food and Drug Administration, some syrup-type children's fever relievers sold in pharmacies have been found to contain crystallization, prompting a recall order.


On the 24th, according to the administration, certain products of "NaeRin Syrup (active ingredient: acetaminophen)" produced by TELCON RF PHARMACEUTICAL and sold by Kwangdong Pharmaceutical have exhibited crystallization in the liquid, leading to ongoing recall procedures by the distributors.

The products subject to recall have the manufacturing number 23001 and an expiration date of February 26, 2025.

An official from the administration stated, "We are currently investigating the cause of the crystallization."

 

Alphabiz Reporter Kim SangJin(letyou@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사